PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26799187-0	2016	p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.	Paclitaxel	42-52	tumor protein p53	Homo sapiens	72-75	
26799187-9	2016	These results suggest for the first time that the p38 MAPK/p53/EGFR axis is crucial for the facilitation of PTX resistance in NSCLCs.	Paclitaxel	108-111	tumor protein p53	Homo sapiens	59-62	
26799187-11	2016	These results provide a foundation for the future development of potential therapeutic strategies to regulate the p38 MAPK/p53/EGFR pathway for the treatment of lung cancer patients with PTX resistance.	Paclitaxel	187-190	tumor protein p53	Homo sapiens	123-126